Erin Burkhart

Insider Reports History

Entity
Individual
Location
C/O Biomarin Pharmaceutical Inc., 770 Lindaro St., San Rafael, California
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erin Burkhart:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIOMARIN PHARMACEUTICAL INC GVP, Chief Accounting Officer Common Stock 15,163 $1.17 M $76.97 May 17, 2024 Direct
BIOMARIN PHARMACEUTICAL INC GVP, Chief Accounting Officer Stock Option (Right to Buy Common Stock) 7,050 Mar 15, 2024 Direct

Insider Reports Filed by Erin Burkhart

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BMRN BIOMARIN PHARMACEUTICAL INC May 17, 2024 1 -76,431 4 May 20, 2024 GVP, Chief Accounting Officer
BMRN BIOMARIN PHARMACEUTICAL INC Apr 10, 2024 1 -205,740 4 Apr 12, 2024 GVP, Chief Accounting Officer
BMRN BIOMARIN PHARMACEUTICAL INC Mar 15, 2024 3 -31,200 4 Mar 19, 2024 GVP, Chief Accounting Officer
BMRN BIOMARIN PHARMACEUTICAL INC May 16, 2023 1 -73,248 4 May 18, 2023 GVP, Chief Accounting Officer
BMRN BIOMARIN PHARMACEUTICAL INC Mar 15, 2023 2 0 4 Mar 17, 2023 GVP, Chief Accounting Officer
BMRN BIOMARIN PHARMACEUTICAL INC May 16, 2022 2 0 4 May 18, 2022 GVP, Chief Accounting Officer
BMRN BIOMARIN PHARMACEUTICAL INC May 2, 2022 0 0 3 May 11, 2022 GVP, Chief Accounting Officer